Optimal usage of antibacterial sutures for wound closure in clinical trials addressing SSI

Lancet. 2023 May 6;401(10387):1497-1498. doi: 10.1016/S0140-6736(23)00668-2.

Authors

Niels-Derrek Schmitz¹, Liza Ovington², Jesse Berlin³, Shumin Zhang⁴, John Collier²

Affiliations

¹ Ethicon, Bridgewater, NJ 08807, USA. Electronic address: nschmit3@its.jnj.com.
² Ethicon, Bridgewater, NJ 08807, USA.
³ Center for Pharmacoepidemiology and Treatment, Rutgers University, New Brunswick, NJ, USA.
⁴ Johnson & Johnson, New Brunswick, NJ, USA.

PMID: 37149304
DOI: 10.1016/S0140-6736(23)00668-2

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-Bacterial Agents* / therapeutic use
Anti-Infective Agents, Local* / therapeutic use
Humans
Surgical Wound Infection / prevention & control
Sutures

Substances

Anti-Bacterial Agents
Anti-Infective Agents, Local